ConductScience.org, home

Paper17545302

Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.

Nakagawa T. Am J Physiol Renal Physiol, 2007. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Papers, record 17545302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17545302

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.
PubMed
Journal
Am J Physiol Renal Physiol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
3.03
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakagawa TTakahiko

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic NeuropathiesMajor topic
Endothelium, VascularMajor topic
Nitric OxideMajor topic
Vascular Endothelial Growth Factor AMajor topic
Animals
Humans
Mice
Mice, Knockout
Neovascularization, Pathologic
Nitric Oxide Synthase Type III

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DK-52121NIDDK NIH HHSUnited StatesR01DK052121PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
41942617The evaluation of an HIV-PrEP drug on the vascular health outcomes in a diet-induced prediabetes condition rat model.Sci Rep2026https://conductscience.org/library/papers/41942617PubMed
41872605The endothelium response to kidney injury.Nat Rev Nephrol2026https://conductscience.org/library/papers/41872605PubMed
41258550Binge drinking as a potential cardiometabolic risk factor during adolescence in rats: novel protective antinitrosative mechanism of folic acid via caveolin-1.Hypertens Res2026https://conductscience.org/library/papers/41258550PubMed
41145714Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF.Hypertens Res2026https://conductscience.org/library/papers/41145714PubMed
40935879Mechanisms of diabetic kidney disease and established and emerging treatments.Nat Rev Endocrinol2026https://conductscience.org/library/papers/40935879PubMed
40534661Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40534661PubMed
39434726Impact of diabetes mellitus and hypertension on renal function during first-line targeted therapy for metastatic renal cell carcinoma: a retrospective multicenter study.Transl Androl Urol2024https://conductscience.org/library/papers/39434726PubMed
39382984Targeting Krüppel-Like Factor 2 as a Novel Therapy for Glomerular Endothelial Cell Injury in Diabetic Kidney Disease.J Am Soc Nephrol2025https://conductscience.org/library/papers/39382984PubMed
38981608Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease.Am J Physiol Cell Physiol2024https://conductscience.org/library/papers/38981608PubMed
37900932A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib.Case Rep Nephrol Dial2023https://conductscience.org/library/papers/37900932PubMed
36986570Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/36986570PubMed
36718295Blood Glucose, HbA1c Level, and its Correlation with VEGF-A (+405G/C) Polymorphism as Biomarker Predicts the Risk of Retinopathy and Nephropathy in Type 2 Diabetic Patients.Rep Biochem Mol Biol2022https://conductscience.org/library/papers/36718295PubMed
36364178Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.Molecules2022https://conductscience.org/library/papers/36364178PubMed
35618410Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases.Ren Fail2022https://conductscience.org/library/papers/35618410PubMed
34781638Fructose in the kidney: from physiology to pathology.Kidney Res Clin Pract2021https://conductscience.org/library/papers/34781638PubMed
34489711Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction.Front Pharmacol2021https://conductscience.org/library/papers/34489711PubMed
34220855Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease.Front Immunol2021https://conductscience.org/library/papers/34220855PubMed
33737643A dose-escalating toxicology study of the candidate biologic ELP-VEGF.Sci Rep2021https://conductscience.org/library/papers/33737643PubMed
33655322Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review).Mol Med Rep2021https://conductscience.org/library/papers/33655322PubMed
32253274Fructose Production and Metabolism in the Kidney.J Am Soc Nephrol2020https://conductscience.org/library/papers/32253274PubMed

See all 62 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17545302

GET https://conductscience.org/api/papers/v1/17545302/cited_by?page=2